| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/04/2010 | US7709629 siRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2) |
| 05/04/2010 | US7709627 Oligonucleotide primer set for amplifying target sequence(s) of norovirus, oligonucleotide probe or probe set specifically hybridizing with target sequence(s) of norovirus, microarray immobilized with the probe or probe set, and method of detecting norovirus using the probe or probe set |
| 05/04/2010 | US7709626 Primer for nucleic acid detection |
| 05/04/2010 | US7709625 Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy |
| 05/04/2010 | US7709619 DNAzymes and sensors incorporating the same |
| 05/04/2010 | US7709618 BTL-II nucleic acids |
| 05/04/2010 | US7709616 Micrornas and uses thereof |
| 05/04/2010 | US7709606 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
| 05/04/2010 | US7709603 PRO1190 polypeptides |
| 05/04/2010 | US7709455 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/04/2010 | US7709454 Antitumor agents; antiproliferative agents; neurodegenerative diseases; using interfering rna; antagonist hedgehog gene; blocking antibodies |
| 05/04/2010 | US7709453 Modulation of the RNA interference pathway |
| 05/04/2010 | US7709451 Method and composition for treating immune complex associated disorders |
| 05/04/2010 | US7709273 light emitting compositions that comprise a polymeric matrix having dissolved therein a photoactive compound; kits for use in an assay |
| 05/04/2010 | US7709271 Method and device for immunoassay |
| 05/04/2010 | US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 05/04/2010 | US7709262 allows sensitive and accurate detection and quantification of nucleic acids containing rare changes and which can be easily automated and scaled up to accommodate testing of large numbers of sample |
| 05/04/2010 | US7709258 High throughput assay for identifying compounds capable of modulating the proliferative status of stem cells |
| 05/04/2010 | US7709256 Disease model incorporation into an artificial immune system (AIS) |
| 05/04/2010 | US7709248 Apparatus for dropping a solution of fluorescence-labeled target substance onto a detection substance within a reaction region; DNA chips and identifying single nucleotide polymorphisms; bioinformatics |
| 05/04/2010 | US7709246 Device and method for detecting bioelectric signals from electrophysiologically active regions in spheroids |
| 05/04/2010 | US7709245 Systems for genome selection |
| 05/04/2010 | US7709244 Systems for genome selection |
| 05/04/2010 | US7709243 Microarray comprising high density of biomolecular probes opreably linked to carbon nanotubes or nanowires for precise detection of preferential biopolymer sequences |
| 05/04/2010 | US7709240 Heat resistant adenyl deaminase for enhancing taste in yeast extract; producing seasoning agent 5'-inosinic acid |
| 05/04/2010 | US7709239 Expression vector comprising nucleotide sequences coding oxidoreductase for use in generation and propagation of oils containing long-chain polyunsaturated fatty acids in yeast |
| 05/04/2010 | US7709233 Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer |
| 05/04/2010 | US7709232 Determining content ratio of genetic recombinant in a sample |
| 05/04/2010 | US7709223 Method for detecting bacteria with chromogenic substrates for β-D-ribofuranosidase |
| 05/04/2010 | US7709222 based upon quantification of biomarkers such as thymidylate synthase in subcellular compartments; colon cancer; treatment by administering 5-fluorouracil (5-FU) |
| 05/04/2010 | US7709221 Biosensor with inorganic-organic hybrid polymer coating |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 05/04/2010 | US7709218 Tumor necrosis factor receptors 6α and 6β |
| 05/04/2010 | US7709216 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death |
| 05/04/2010 | US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders |
| 05/04/2010 | US7709211 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 05/04/2010 | US7709206 Using presence of single nucleotide polymorphism as evaluative tool in determining animal health, meat quality and edibility |
| 05/04/2010 | US7709205 Antiproliferative agents; antiapoptosis; drug screening; blot analysis; immunohistochemistry; RNA interference; fluorescence in situ hybridization; determining prognosis in a subject with breast cancer, comprising determining overexpression of 14-3-3 zeta mRNA |
| 05/04/2010 | US7709204 used to determine whether or not a mammal (e.g., a human) with a brain aneurysm is likely to experience brain aneurysm rupture by determining whether two or more polymorphisms are selected from the group consisting of 27 VNTR, T-786C SNP, and G894T SNP |
| 05/04/2010 | US7709203 Diagnostic primers for detecting vibrio harveyi infestation of shrimp in aquaculture farms |
| 05/04/2010 | US7709202 Molecular characteristics of non-small cell lung cancer |
| 05/04/2010 | US7709201 Detection of nucleic acid differences using endonuclease cleavage/ligase resealing reactions and capillary electrophoresis or microarrays |
| 05/04/2010 | US7709200 Association of PDE4D allelic variants with stroke |
| 05/04/2010 | US7709199 Chronic lymphocytic leukaemia |
| 05/04/2010 | US7709198 Multiplex detection of nucleic acids |
| 05/04/2010 | US7709197 Nucleic acid analysis by random mixtures of non-overlapping fragments |
| 05/04/2010 | US7709196 rRNA genes from E. coli and other disease causing organisms are genetically engineered to allow identification of functional mutant ribosomes that may be used as drug targets |
| 05/04/2010 | US7709195 Hybridization detecting unit relying on dielectrophoresis and sensor chip provided with the detecting unit |
| 05/04/2010 | US7709194 Marker for prenatal diagnosis and monitoring |
| 05/04/2010 | US7709193 Detecting preferential polypeptides in sample; obtain biological sample, incubate with reducing agent and detergent, detect and extract protein from solution; useful in assessing damage to cells such as cardiac and skeletal muscle cells and in the early clinical diagnosis of myocardial damage |
| 05/04/2010 | US7709192 Binding ligand to nucleic acids; detection |
| 05/04/2010 | US7709191 for measuring the therapeutic efficacy of various HIV treatment regimes such as highly active antiretroviral therapy (HAART); Using CCR5 and CXCR4 coreceptor usage as diagnostic indicator of AIDS disease progression in patients; determining most effective antiviral treatments for AIDS patients |
| 05/04/2010 | US7709190 Influenza A virus vaccines and inhibitors |
| 05/04/2010 | US7709189 Methods for identifying or diagnosing carcinoma cells with metastatic potential based on the measurement of lymphoid genes or their products in carcinoma cells |
| 05/04/2010 | US7709188 Multi-allelic detection of SARS-associated coronavirus |
| 05/04/2010 | US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes |
| 05/04/2010 | US7709006 Hepatitis-C virus testing |
| 05/04/2010 | US7709004 Method of producing an HIV-1 immune response |
| 05/04/2010 | US7709003 Method of producing an HIV-1 immune response |
| 05/04/2010 | US7708998 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 05/04/2010 | US7708984 Using immunoglobulin specific to adenoid expressed chemokine (ADEC) for prevention and treatment of cell proliferative, glandular and viral infection |
| 05/04/2010 | US7708945 Device and method for determining multiple analytes |
| 05/04/2010 | CA2634654C Reagent compositions for analytical testing |
| 05/04/2010 | CA2571339C Stable cell lines expressing herg |
| 05/04/2010 | CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition |
| 05/04/2010 | CA2421492C Method of sequencing dna |
| 05/04/2010 | CA2412880C Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |
| 05/04/2010 | CA2398362C Homogenous assay of duplex or triplex hybridization by means of multiple measurements under varied conditions |
| 05/04/2010 | CA2281920C Compositions and methods for modulating cellular nf-.kappa.b activation |
| 05/04/2010 | CA2089376C Sugar modified oligonucleotides that detect and modulate gene expression |
| 04/30/2010 | CA2665773A1 Neurotoxic sterol glycosides |
| 04/29/2010 | WO2010048526A2 Modulators of cystic fibrosis transmembrane conductance regulator |
| 04/29/2010 | WO2010048511A1 Antibiotic susceptibility profiling methods |
| 04/29/2010 | WO2010048497A1 Genetic profile of the markers associated with alzheimer's disease |
| 04/29/2010 | WO2010048424A1 Methods, compositions, and kits for diagnosing, monitoring, and treating disease |
| 04/29/2010 | WO2010048415A1 Methods of using jak3 genetic variants to diagnose and predict crohn's disease |
| 04/29/2010 | WO2010048386A1 Methods of sample preparation for nucleic acid analysis for nucleic acids available in limited amounts |
| 04/29/2010 | WO2010048378A2 Genetic markers for weight management and methods of use thereof |
| 04/29/2010 | WO2010048347A2 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 04/29/2010 | WO2010048337A2 Preservation of information related to genomic dna methylation |
| 04/29/2010 | WO2010048317A2 Micro-rnas as markers for tumor progression |
| 04/29/2010 | WO2010048306A1 High-throughput assay for evaluating dipeptidyl peptidase i activity |
| 04/29/2010 | WO2010048304A2 Identification of signature genes associated with hepatocellular carcinoma |
| 04/29/2010 | WO2010048252A1 Lawsonia intracellularis vaccines |
| 04/29/2010 | WO2010048212A2 Methods and compositions for preventing artifacts in tissue samples |
| 04/29/2010 | WO2010048123A2 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 04/29/2010 | WO2010048020A1 Methods and systems for improved pharmaceutical intervention in coagulation control |
| 04/29/2010 | WO2010048002A1 Target detection using a single-stranded, self-complementary, triple-stem dna probe |
| 04/29/2010 | WO2010047868A1 Receptor tyrosine kinase assays |
| 04/29/2010 | WO2010047797A2 Single quantum-dot-based aptameric sensors |
| 04/29/2010 | WO2010047781A2 Filtered assay device and method |
| 04/29/2010 | WO2010047780A2 Multiple filter array assay |
| 04/29/2010 | WO2010047779A2 Integrated bioanalyzer |
| 04/29/2010 | WO2010047778A1 Compositions for the detection of intracellular bacterial targets and other intracellular microorganism targets |
| 04/29/2010 | WO2010047619A1 Method for determining nucleic acids by real-time polymerase chain reaction and a device for the implementation thereof |
| 04/29/2010 | WO2010047561A2 Diagnostic kit for predicting the prognosis of invasive or non-muscle invasive bladder cancer, method for predicting the prognosis of bladder cancer, and bladder cancer medicine screening method |
| 04/29/2010 | WO2010047519A2 Heart tissue specific gene mmh1 |
| 04/29/2010 | WO2010047317A1 Novel marker for detecting interstitial cystitis |
| 04/29/2010 | WO2010047240A1 Method for predicting risk of exudative age-related macular degeneration |
| 04/29/2010 | WO2010047211A1 Method for determining presence or absence of abnormal cell |